This review highlights the rapid advancement and expanding indications of transcatheter therapies for various structural heart diseases.
Transcatheter approaches predominate for ASD/PFO; leaves comparative efficacy and durability open for emerging structural indications.
Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as standard procedure for atrial septal defect and patent foramen ovale closure. Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement. Until recently, therapy for these diseases was limited to patients in whom severe comorbidities lead to contraindications to surgery. Techniques to treat heart failure caused by left ventricular aneurysms or to prevent cardioembolic stroke by percutaneous occlusion of the left atrial appendage in patients with atrial fibrillation are emerging. This article reviews current indications and recent developments in interventional treatment of structural heart disease.
No takes yet. Share an insight, caveat, or question.
Franke et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: